We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

99 hedge funds and large institutions have $239M invested in GenMark Diagnostics, Inc in 2017 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 36 increasing their positions, 24 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 24

20% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 15

3% more funds holding

Funds holding: 96 → 99 (+3)

58% less capital invested

Capital invested by funds: $571M → $239M (-$332M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
99
Holders Change
+3
Holders Change %
+3.13%
% of All Funds
2.24%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
18
Increased
36
Reduced
24
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$13.4M
2
CC
Casdin Capital
New York
+$7.4M
3
CCM
Cadian Capital Management
New York
+$5.93M
4
Bank of America
Bank of America
North Carolina
+$3.4M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$3.31M

Top Sellers

Rank Fund Capital Flow
1
Artisan Partners
Artisan Partners
Wisconsin
-$21.4M
2
NC
Northpointe Capital
Michigan
-$15M
3
Jennison Associates
Jennison Associates
New York
-$11.1M
4
Millennium Management
Millennium Management
New York
-$5.21M
5
PI
Putnam Investments
Massachusetts
-$4.62M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$1.01M -$27.8K -4,616 -2%
Charles Schwab
27
Charles Schwab
California
$943K +$54.4K +9,048 +4%
GIP
28
Granite Investment Partners
California
$900K +$786K +130,677 +154%
Federated Hermes
29
Federated Hermes
Pennsylvania
$834K – – –
NIM
30
Needham Investment Management
New York
$750K +$740K +123,000 +216%
TCIM
31
TIAA CREF Investment Management
New York
$732K +$29.1K +4,829 +3%
TD Asset Management
32
TD Asset Management
Ontario, Canada
$728K +$266K +44,236 +34%
Russell Investments Group
33
Russell Investments Group
United Kingdom
$648K +$467K +77,545 +106%
WMSA
34
Weiss Multi-Strategy Advisers
New York
$630K +$349K +58,000 +62%
SSA
35
Schonfeld Strategic Advisors
New York
$626K -$361K -60,000 -29%
Two Sigma Advisers
36
Two Sigma Advisers
New York
$618K +$892K +148,300 New
TA
37
Teachers Advisors
New York
$522K +$76.5K +12,713 +11%
Deutsche Bank
38
Deutsche Bank
Germany
$485K -$157K -26,029 -18%
William Blair & Company
39
William Blair & Company
Illinois
$389K +$294K +48,849 +110%
Swiss National Bank
40
Swiss National Bank
Switzerland
$371K – – –
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$338K – – –
Citadel Advisors
42
Citadel Advisors
Florida
$336K -$45.3K -7,534 -9%
DCM
43
Donaldson Capital Management
Indiana
$283K +$9.03K +1,500 +2%
RA
44
Royce & Associates
New York
$275K +$397K +65,900 New
Goldman Sachs
45
Goldman Sachs
New York
$229K -$164K -27,201 -33%
Wells Fargo
46
Wells Fargo
California
$225K +$38.7K +6,432 +14%
FA
47
FDx Advisors
Illinois
$224K +$179K +29,729 +124%
FC
48
Fairpointe Capital
Illinois
$220K +$317K +52,658 New
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$211K – – –
ARTA
50
A.R.T. Advisors
New York
$209K +$302K +50,190 New
1
2
3 4 5

GNMK Hedge Fund Activity: Q4 2017 in Review

99 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q4 2017, worth a combined $239M — down 58% from $571M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new GNMK positions and 15 closed out — a net gain of 3 holders — while 36 added to existing stakes and 24 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $13.4M. The largest seller was Artisan Partners, exiting entirely with an estimated $21.4M sold.

  • 99 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q4 2017, up from 96 in Q3 2017.
  • Funds reported $239M of GenMark Diagnostics, Inc stock for Q4 2017, down 58% quarter-over-quarter.
  • 18 funds opened new GenMark Diagnostics, Inc positions in Q4 2017 and 15 closed out, a net change of +3 holders.
  • The largest GenMark Diagnostics, Inc buyer in Q4 2017 was T. Rowe Price Associates, an estimated $13.4M added.
  • The largest GenMark Diagnostics, Inc seller in Q4 2017 was Artisan Partners, an estimated $21.4M sold.

Based on aggregated 13F filings for Q4 2017.